Immunome Ownership | Who Owns Immunome?
Immunome Ownership Summary
Immunome is owned by 49.36% institutional investors, 7.85% insiders, and 42.79% retail investors. Blackrock is the largest institutional shareholder, holding 36.46% of IMNM shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.58% of its assets in Immunome shares.
IMNM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunome | 49.36% | 7.85% | 42.79% |
| Sector | Healthcare Stocks | 231.98% | 10.74% | -142.72% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 3.76M | 36.46% | $45.48M |
| Fmr | 13.06M | 15.01% | $152.89M |
| T. rowe price investment management | 8.42M | 9.67% | $98.58M |
| Blackrock funding, inc. /de | 7.59M | 8.63% | $163.14M |
| Vanguard group | 6.04M | 6.87% | $129.71M |
| Redmile group | 5.02M | 5.77% | $58.82M |
| Janus henderson group | 3.46M | 5.74% | $36.73M |
| Point72 asset management | 4.82M | 5.54% | $56.49M |
| Enavate sciences gp | 4.77M | 5.48% | $55.84M |
| Primecap management co/ca/ | 4.69M | 5.33% | $100.64M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Enavate sciences gp | 4.77M | 17.05% | $55.84M |
| Redmile group | 5.02M | 5.72% | $58.82M |
| Opaleye management | 3.19M | 5.27% | $37.30M |
| Pivotal bioventure partners investment advisor | 502.51K | 3.40% | $5.88M |
| Silverarc capital management | 1.13M | 3.36% | $24.19M |
| Monashee investment management | 274.86K | 3.33% | $5.90M |
| Ecor1 capital | 4.08M | 2.29% | $47.77M |
| Nan fung trinity (hk) | 714.55K | 1.22% | $15.35M |
| Birchview capital, lp | 105.00K | 0.93% | $1.23M |
| Readystate asset management lp | 1.32M | 0.66% | $15.44M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 13.06M | 0.01% | 6.89M |
| Blackrock | 3.76M | 0.00% | 2.93M |
| Jpmorgan chase | 2.86M | 0.00% | 2.82M |
| Blackrock funding, inc. /de | 7.59M | 0.00% | 1.77M |
| Primecap management co/ca/ | 4.69M | 0.08% | 1.67M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Toronto dominion bank | 1.04M | 0.02% | -1.05M |
| Vestal point capital, lp | - | - | -1.00M |
| Avidity partners management lp | - | - | -873.89K |
| Brown advisory | - | - | -860.78K |
| Adage capital partners gp | - | - | -775.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Silverarc capital management | 1.13M | 3.36% | 1.13M | $24.19M |
| Pivotal bioventure partners investment advisor | 502.51K | 3.40% | 502.51K | $5.88M |
| Parkman healthcare partners | 351.13K | 0.43% | 351.13K | $4.11M |
| Monashee investment management | 274.86K | 3.33% | 274.86K | $5.90M |
| Axa investment managers | 180.06K | 0.01% | 180.06K | $2.11M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Eversource wealth advisors | -8.00 |
| Us bancorp \de\ | -21.00 |
| Lindbrook capital | -38.00 |
| Stephens consulting | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 109 | -33.54% | 43,416,568 | -52.49% | 49 | 0.45% | 67 | -27.96% | 23 | -37.84% |
| Sep 30, 2025 | 160 | 8.11% | 91,368,868 | 15.03% | 105 | 1.26% | 91 | 7.06% | 37 | - |
| Jun 30, 2025 | 148 | 0.68% | 79,432,018 | 9.01% | 91 | 1.08% | 85 | -20.56% | 37 | 105.56% |
| Mar 31, 2025 | 147 | 18.55% | 76,924,342 | 44.29% | 96 | 1.24% | 108 | 54.29% | 17 | -51.43% |
| Dec 31, 2024 | 123 | 1.65% | 53,309,287 | 3.16% | 88 | 1.20% | 69 | 4.55% | 35 | 25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 6.16M | 5.58% | 693.09K |
| T. Rowe Price US Small-Cap Core Equity | 5.13M | 4.65% | 2.01M |
| T. Rowe Price Small-Cap Stock | 5.13M | 4.65% | 220.26K |
| Fidelity Growth Company Fund | 4.42M | 4.01% | 475.95K |
| PRIMECAP Odyssey Aggressive Growth | 3.81M | 3.46% | 1.14M |
| Fidelity Growth Compy Commingled Pl O | 1.79M | 2.97% | - |
| Vanguard Total Stock Mkt Idx Inv | 3.14M | 2.84% | 10.48K |
| T. Rowe Price Instl Small-Cap Stock | 2.78M | 2.52% | 147.91K |
| T. Rowe Price U.S. SC Core Eq Tr-D | 2.36M | 2.14% | 914.28K |
| iShares Russell 2000 ETF | 2.25M | 2.04% | 2.25M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 30, 2025 | SIEGALL CLAY B | President and CEO | Buy | $100.02K |
| Dec 22, 2025 | Barchas Isaac | - | Sell | $251.35K |
| Dec 22, 2025 | Barchas Isaac | - | Sell | $8.08M |
| Dec 19, 2025 | SIEGALL CLAY B | President and CEO | Buy | $149.05K |
| Dec 19, 2025 | Tsai Philip | Chief Technical Officer | Buy | $204.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 4 | 2 |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | 5 | - |
| 2024 Q4 | 4 | - |
IMNM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools